The latest report by IMARC Group, titled “Bromelain Market Report by Source (Stem, Fruit), Application (Healthcare, Food and Beverages, Cosmetics, and Others), and Region 2024-2032“, The global bromelain market size is expected to exhibit a growth rate (CAGR) of 6.3% during 2024-2032.
Bromelain is a proteolytic enzyme derived from the fruit, stem, and juice of the pineapple plant. It plays a significant role in inhibiting the aggregation of blood platelets, thereby lowering the risk of arterial thrombosis and embolism, making it a common choice for the treatment of cardiovascular diseases (CVDs). This enzyme also possesses compounds that disrupt tumor cell activity and slow down the clotting process. Furthermore, bromelain stimulates the production of substances that combat swelling and pain, and it acts as a fibrinolytic agent by facilitating the conversion of plasminogen to plasmin, which aids in fibrinolysis. Additionally, when used as a topical cream, it effectively removes damaged tissue from wounds and second and third-degree burns, serving as a popular alternative to nonsteroidal anti-inflammatory drugs (NSAIDs) in homeopathic practices. It also helps reduce swelling, congestion, and joint stiffness, and is beneficial in treating inflammatory bowel disorders. Due to these numerous advantages, bromelain is extensively utilized in the healthcare, cosmetics, and food and beverage (F&B) industries worldwide.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/bromelain-market/requestsample
Bromelain Market Trends and Drivers:
The market is largely influenced by the growth of the healthcare sector. Additionally, the increasing prevalence of conditions such as cancer, asthma, rheumatoid arthritis, and cardiovascular diseases (CVDs) is further propelling market expansion. Correspondingly, the heightened demand for bromelain within the pharmaceutical industry, attributed to its anti-inflammatory and analgesic effects, is significantly impacting market dynamics. Bromelain is frequently utilized as a dietary supplement to mitigate post-surgical pain and bruising, and it also alleviates symptoms related to osteoarthritis, diarrhea, and diabetes, while improving the absorption of medications, including antibiotics. Furthermore, the extensive use of bromelain by athletes to manage acute inflammation from injuries serves as another critical factor driving market growth. It is also effective in treating chronic inflammatory, malignant, and autoimmune disorders. In addition, the increasing requirement for bromelain to maintain its efficacy when absorbed in the intestines is boosting its application as an oral enzyme therapy for oncology patients. The rising demand for bromelain in the food and beverage (F&B) sector, particularly in the meat and seafood industry for tenderizing purposes, is also contributing to market growth. Moreover, the bromelain market is experiencing varied growth rates across different regions, with North America emerging as one of the largest markets due to the escalating demand in healthcare, rising disposable incomes, and growing awareness of bromelain’s benefits. The industry is anticipated to encounter heightened competition in the coming years, as key players adopt various strategies to maintain their market presence. For example, in 2017, Advanced Enzymes Technologies Limited acquired a 100% stake in evoxx technologies GmbH, a company based in Germany. This strategic acquisition enhanced Advanced Enzymes’ research and development (R&D) capabilities.